Le infezioni in medicina最新文献

{"title":"Monkeypox virus infections in low-risk groups during the 2022-23 global outbreak: An analysis of the WHO global report.","authors":"Max Carlos Ramírez-Soto, Hugo Arroyo-Hernández","doi":"10.53854/liim-3201-2","DOIUrl":"10.53854/liim-3201-2","url":null,"abstract":"<p><strong>Introduction: </strong>In the 2022-23 Mpox outbreak, cases also occurred in children, adolescents, and adults aged 50 years and older, for whom the risk of transmission is low and whose epidemiological characteristics are less known, compared to high-risk groups such as young adults. Here we describe the epidemiological characteristics of Mpox in children, adolescents and adults aged 50 years and older in the global Mpox outbreak.</p><p><strong>Methods: </strong>A retrospective study on laboratory-confirmed surveillance data of Mpox cases reported to World Health Organization (WHO) was conducted. Case data from WHO's 2022-23 Mpox Outbreak: Global Trends from 1 January 2022 to 1 September 2023 was used for our analysis. We included cases reported by WHO with data on age (children [range, 0 to 9 years], adolescents [range, 10 to 17 years], adults 50 to 59 years, and adults 60 years and older), gender, WHO region, hospital admission, and intensive care unit admission.</p><p><strong>Results: </strong>Until September 01, 2023, data from 89,752 cases of Mpox have been reported to WHO. Of all the reported cases, 1124 (1.3%), 6296 (7.0%) and 1501 (1.6%) were children and adolescents, adults aged 50-59 years, and adults aged 60 years or older, respectively, and the proportion varied among WHO regions. There was a high proportion of cases among population aged 0-17 years, adolescents (256 [66.3%]) from the region of the Americas and girls aged 0-9 years [127 (46.7%)] from the African region. Men aged 50-59 years (3495 [57.2%] vs. 2553 [41.8%] cases from the region of the Americas and the European region, respectively) and men aged 60-69 years (639 [60.0%] vs. 607 [48.4%] from the region of the Americas and the European region) were most affected, compared to other age groups and women. Among children, adolescents, and adults aged 50 years or older, a low proportion of cases developed some complications and required hospital admission, and some cases were admitted to the intensive care unit.</p><p><strong>Conclusions: </strong>Epidemiological evidence of Mpox in these low-risk groups highlights the risk of wider community transmission. Therefore, while efforts continue to control the global outbreak of Mpox in high-risk groups, it is also necessary to ensure that these low-risk groups have access to timely health care and vaccination.</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"32 1","pages":"12-19"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10917560/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140061724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Investigating the diagnostic and prognostic value of anti-SARS-CoV-2 Spike IgG/IgM ELISA tests in patients infected with coronavirus Delta variant.","authors":"Mandana Pouladzadeh, Mofid Hosseinzadeh, Reza Khedri, Parastoo Moradi Choghakabodi, Payam Amini, Alireza Ghorbani Bavani, Hossein Bahrami Moghaddam, Babak Behmanesh, Ali Delirrooyfard, Alireza Sokooti, Behnam Sheibani","doi":"10.53854/liim-3201-4","DOIUrl":"10.53854/liim-3201-4","url":null,"abstract":"<p><strong>Aim: </strong>This study aimed to investigate the diagnostic and prognostic value of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike IgG/IgM antibodies in patients infected with coronavirus Delta variant.</p><p><strong>Methods: </strong>This analytical observational study included 270 unvaccinated patients (aged ≥18 years) diagnosed with coronavirus disease 2019 (COVID-19) Delta variant who referred to Emergency Department of our hospital. The serum levels of anti-SARS-CoV-2 Spike IgG and IgM were measured by indirect ELISA. Main measured outcomes included anti-SARS-CoV-2 Spike IgG and IgM, chest computed tomography (CT) severity score, clinical and laboratory findings which were prospectively evaluated throughout the study period.</p><p><strong>Results: </strong>The IgM levels in critical patients were significantly higher than non-critical patients (p<0.05). But the mean level of IgG in critical patients was not significantly different from its level in non-critical patients (p>0.05). However, a significant positive correlation was observed between the levels of both antibodies and chest CT severity score (p<0.0001); this implies that their levels may reflect the degree of lung involvement. The IgM level on 15^th-16^th days after symptoms onset was significantly associated with the hazard of death even after adjusting for all other factors (adjusted HR (95%CI):1.28(1.014_1.63), p=0.03), whereas IgG was not (p>0.05). The survival probability among patients with IgM level ≥8.67 RU/ml (34.2%) was significantly lower than those with IgM level <8.67 RU/ml (99.5%, p=0.0001).</p><p><strong>Conclusions: </strong>Anti-SARS-CoV-2 Spike IgM antibody was significantly associated with the disease severity and risk of death in unvaccinated patients infected with coronavirus Delta variant. However, further large-scale investigations on diverse infected populations are required to precisely determine the diagnostic/prognostic value of these antibodies.</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"32 1","pages":"25-36"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10917556/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140061723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Presumptive pulmonary toxocariasis in a patient affected by acute myeloid leukemia and Hodgkin lymphoma: case report and review of the literature in immunocompromised hosts.","authors":"Tommaso Lupia, Elena Crisà, Valentina Sangiorgio, Roberta Bosio, Giacomo Stroffolini, Elena Staffilano, Vanesa Gregorc, Silvia Corcione, Francesco Giuseppe De Rosa","doi":"10.53854/liim-3201-14","DOIUrl":"10.53854/liim-3201-14","url":null,"abstract":"<p><p>Toxocariasis is a zoonosis transmitted by the nematode <i>Toxocara</i> spp. Immunocompromised hosts are more susceptible than general population to bacterial, viral, fungal and parasitic infections. In this population toxocariasis may present as exacerbation or reactivation and could have severe or atypical manifestations being a diagnostic challenge for healthcare providers. We report a case of a presumptive pulmonary toxocariasis during chemotherapy in a patient affected by acute myeloid leukaemia (AML) and Hodgkin lymphoma and we summarize current evidence of pulmonary involvement in immunocompromised population with <i>Toxocara</i> spp infection in a narrative review. The aim of this work is also to revise the current literature on pulmonary involvement during <i>Toxocara</i> spp infection in immunocompromised hosts to improve knowledge on clinical presentation, treatment and outcome. A 66 years old man who had undergone to a cytarabine and idarubicin chemotherapy induction scheme for AML, complained of febrile neutropenia and dry cought. At the chest computed tomography (CT) there were multiple nodular pulmonary lesions with subpleural consolidations. The lung biopsy revealed inflammatory infiltration with diffuse small granulomas with minor eosinophil component. The laboratory analysis showed high immunoglobulin E (IgE) count with normal peripherical eosinophils, among the extended parasitological analysis, <i>Toxocara</i> immunoblot assay resulted positive. In the most accepted hypothesis of a polmunary toxocariasis infection, the patient was treated with a combination of albendazole plus corticosteroids for four weeks, with a positive outcome. Infection complications during chemotherapy are not uncommon, however, this is the first reported case of pulmonary toxocariasis during cytarabine and idarubicin treatment in AML. The revised literature shows male gender and younger age as possible risk factors, nevertheless the majority of cases of seropositivity for Toxocara was reported in solid organ malignancies. In this case, the suspect was mainly based on laboratory total elevated IgE, confirmed by serological, anatomo-pathological and radiological findings. Hypereosinophilia is often not present in chronic infection. In conclusion, pulmonary toxocariasis should be ruled out in patients with pulmonary involvement and high IgE titre, with or without peripheral eosinophilia, especially in those with known immunocompromised status.</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"32 1","pages":"103-112"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10917563/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140061695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"COVID-19 vaccines-associated Takotsubo cardiomyopathy: A narrative review.","authors":"Shakiba Hassanzadeh, Addi Suleiman, Joaquim J Correia, Sahar Memar Montazerin","doi":"10.53854/liim-3201-1","DOIUrl":"10.53854/liim-3201-1","url":null,"abstract":"<p><p>Takotsubo cardiomyopathy (TTC) is a severe, acute, reversible, and self-limited cardiac dysfunction. It usually affects postmenopausal women and is mostly triggered by physical or emotional stressors. Following the COVID-19 pandemic, millions of doses of different types of COVID-19 vaccines are being administered globally. There have been reports of different cardiac complications after receiving COVID-19 vaccines. To our knowledge, there have been 16 reported cases of COVID-19 vaccination-associated TTC. In this study, we first provide a brief overview of TTC and then an overview of selected reported TTC cases following COVID-19 vaccinations. It is crucial to highlight that the occurrence of TTC after vaccination does not establish a direct cause-and-effect relationship between immunization and TTC. Further investigations are necessary to examine any potential association between COVID-19 vaccines and the incidence of TTC. Additionally, the benefits of receiving COVID-19 vaccines significantly outweigh the potential risks of developing adverse events.</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"32 1","pages":"1-11"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10917559/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140061719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Seroprevalence of <i>Chlamydia trachomatis</i> and associated risk factors among HIV positive women in North Central Nigeria.","authors":"Pius Omoruyi Omosigho, Tope Elizabeth Ajide, Osazee Ekundayo Izevbuwa, Olalekan John Okesanya, Janet Mosunmola Oladejo, Paulinus Osarodion Uyigue","doi":"10.53854/liim-3201-7","DOIUrl":"10.53854/liim-3201-7","url":null,"abstract":"<p><strong>Introduction: </strong><i>Chlamydia trachomatis</i> infection is among the STDs that are known to increase the risk of HIV infection. The present study aims to determine the seroprevalence of <i>C. trachomatis</i> among HIV positive women in Ilorin and Offa, Kwara State, North Central Nigeria.</p><p><strong>Methods: </strong>Serum samples from 400 HIV positive women attending the HAART Clinic in Offa and the Ilorin General Hospital in Kwara State, Nigeria, were screened using Enzyme Linked Immunosorbent Assay (ELISA), utilizing the immunocomb Chlamydia IgG test kit (Calbiotech, El Cajon, CA, USA) to check for the existence of anti-<i>C. trachomatis</i> antibodies.</p><p><strong>Result: </strong>Anti-<i>C. trachomatis</i> antibodies were present in 92 (23.0%) of the 400 HIV positive women samples. There was a higher prevalence among the age group 36-40 years. Hence, age groupings were statistically and significantly associated (p=0.001) with the seroprevalence of <i>C. trachomatis</i> among HIV positive women. Married HIV positive women (60.9%) had the highest prevalence of <i>C. trachomatis</i>, with a statistically significant association (p=0.001). There was a statistically significant association between the number of sexual partner(s) (p=0.001) and the seroprevalence of <i>C. trachomatis</i> among HIV positive women.</p><p><strong>Conclusions: </strong>The high frequency confirms the necessity for comprehensive sexual education among young adults and routine testing for anti-<i>C. trachomatis</i>. It reflects the endemicity of the infection in Ilorin and Offa Kwara State, Nigeria.</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"32 1","pages":"52-60"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10917553/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140061699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development of a clinical scoring system to make a presumptive diagnosis of Kyasanur Forest Disease: a case-control study from South India.","authors":"Nitin Gupta, Carl Boodman, Kavitha Saravu","doi":"10.53854/liim-3201-8","DOIUrl":"10.53854/liim-3201-8","url":null,"abstract":"<p><strong>Introduction: </strong>Kyasanur Forest Disease (KFD) is a viral haemorrhagic fever endemic in South India. Based on clinical presentation alone, it is challenging to distinguish KFD from other febrile illnesses in the region. The study aimed to develop a clinical scoring system for early presumptive diagnosis of KFD.</p><p><strong>Patients and methods: </strong>This retrospective case-control study included microbiologically diagnosed KFD patients (n=186) with other undifferentiated febrile illnesses as controls (n=203). The clinical and laboratory features between cases and controls were compared. A logistic regression analysis included those variables found to be significantly associated with KFD on univariate analysis. The adjusted odds ratio for the significant variables was calculated and converted into logarithmic scales. These numbers were rounded off to the nearest integer to find the score assigned to each variable. A receiver operating characteristics curve was created to find the best cut-off for the scoring system that predicted the diagnosis of KFD.</p><p><strong>Results: </strong>A total of 186 anonymised cases and 203 anonymised controls were recruited from the records for this study. Myalgia, headache, lymphadenopathy, bleeding manifestations, Central Nervous System (CNS) involvement, raised haematocrit, leukopenia, and raised transaminases were more common in patients with KFD. Except for lymphadenopathy and raised transaminases, all the other variables were independent predictors of making a diagnosis of KFD. Since raised transaminases tended towards significance, it was included in the scoring system with other independent predictors. A scoring system was created with a maximum score of 12. The receiver operating characteristic curve showed an Area Under Curve of 0.912 (95%CI: 0.88-0.94). A score of 4 or more was found to have a sensitivity and specificity of 83% and 87%, respectively.</p><p><strong>Conclusion: </strong>The presence of specific features should alert primary care physicians working in endemic areas about the possibility of KFD. This diagnostic scoring system can be used to make a presumptive diagnosis of KFD after undergoing a prospective validation study.</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"32 1","pages":"61-68"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10917564/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140061720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Risk factors for therapeutic failure in adults with methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) infection treated with vancomycin in a high-complexity hospital in Cali, Colombia.","authors":"Carlos Mauricio Muriel, Jose Fernando García-Goez, Delia Ortega, Diana Martínez, Diego Rosselli","doi":"10.53854/liim-3201-6","DOIUrl":"10.53854/liim-3201-6","url":null,"abstract":"<p><strong>Objective: </strong>To determine the risk factors associated with therapeutic failure of vancomycin in hospitalized adult patients with methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) infections.</p><p><strong>Design: </strong>Case-control study.</p><p><strong>Setting: </strong>Conducted in a high complexity hospital in Cali, Colombia.</p><p><strong>Participants: </strong>Adult hospitalized from January 1, 2015, to December 31, 2021, with MRSA infections with confirmed microbiological isolation.</p><p><strong>Methods: </strong>Cases were patients with therapeutic failure of vancomycin (mortality, poor clinical improvement, change of antibiotic used, early relapse, or persistence of positive blood cultures) and control patients were those who did not present failure. Significant variables from the bivariate analysis were included in a multiple analysis with an asymmetric logistic regression model.</p><p><strong>Results: </strong>A total of 105 patients were included in the study, 28 in the treatment group and 77 in the control group. The median age was 49 years and 59 (56%) of participants were men. The following variables: age (OR 1.034; 95% CI 1.007-1.061, p=0.011), osteomyelitis/ septic arthritis (OR 6.035; 95% CI 2.282-15.956, p=0.000) and minimum inhibitory concentration (MIC) (OR 5.971; 95% CI 1.321-26.979, p=0.020) were found to be independent risk factors associated with therapeutic failure of vancomycin. Vancomycin trough levels were not different between cases and controls (OR 0.976; 95% CI 0.911-1.044, p=0.478).</p><p><strong>Conclusions: </strong>When a multiple analysis was performed to control for confounding factors, only 3 variables were found to be significant and were considered risk factors for therapeutic failure of vancomycin in adult patients with MRSA infection: age, MIC, and osteomyelitis/ septic arthritis.</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"32 1","pages":"45-51"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10917555/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140061698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An unusual case of <i>Brucella melitensis</i>-related wound infection.","authors":"Ozge Alkan Bilik, Fatma Meral Ince, Nida Ozcan, Zeynep Ayaydin","doi":"10.53854/liim-3201-13","DOIUrl":"10.53854/liim-3201-13","url":null,"abstract":"<p><strong>Background: </strong>Brucellosis is an anthropo-zoonotic infectious disease caused by various Brucella species. It is usually transmitted through contact with infected animals or consumption of contaminated animal products. Brucellosis most commonly affects the musculoskeletal and reticuloendothelial system with additional involvement observed in gastrointestinal system, urinary tract, reproductive system, central nervous system, and cardiovascular system. Skin involvement is extremely rare in brucellosis. Here, we report a rare case of <i>Brucella melitensis</i> infection developing in a back wound following a lumbar disc herniation surgery over 14 years ago.</p><p><strong>Case: </strong>A 34-year-old male patient, who had a herniated disc surgery 14 years ago, was admitted to the hospital with complaints of joint pain, sweating and discharge at the surgery site. Wound culture revealed the presence of Gram negative cocobacilli which was identified as <i>Brucella melitensis</i>. The subsequent diagnostic tests, including the Rose-Bengal and Brucella Capture test positivity at a titer of 1/320 confirmed the diagnosis. The patient received six weeks of doxycycline (200 mg/day, orally) and rifampin (600 mg/day orally) treatment, accompanied by wound care procedures. Daily cleaning, sterile dressing, and wound debridement were employed. Following treatment, the patient's condition improved, and wound discharge ceased. Continuous monitoring showed no signs of relapse, achieving complete remission.</p><p><strong>Conclusion: </strong><i>Brucella spp</i>. should be considered as a potential cause of wound infections developing after surgery or trauma in brucellosis-endemic areas. This report also emphasizes the importance of promptly determining the cause of infection before initiating antibiotic treatment.</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"32 1","pages":"99-102"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10917558/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140061716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Asclepieia in ancient Greece: pilgrimage and healing destinations, the forerunner of medical tourism.","authors":"Androula Pavli, Helena C Maltezou","doi":"10.53854/liim-3201-15","DOIUrl":"10.53854/liim-3201-15","url":null,"abstract":"<p><p>Asclepios, the first physician-demigod in Greek mythology, was born in Thessaly of the God Apollo and Coronis, a mortal mother. Asclepieia were healing sanctuaries dedicated to Asclepios. Asclepieia were located throughout the Eastern Mediterranean area, in ancient Greece and the Roman world. Travelers from all over the Mediterranean area seeking healing made pilgrimages to the Asclepieia, the early forerunner of \"medical tourism\".</p>","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"32 1","pages":"113-115"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10917557/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140061717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"HCV screening in hospitalized patients: new challenges and opportunities for the target of microelimination.","authors":"Elena Garlatti Costa, Anna Moratto, Danilo Villalta, Mirella Da Re, Giancarlo Basaglia, Maurizio Tonizzo, Silvia Grazioli","doi":"10.53854/liim-3201-16","DOIUrl":"10.53854/liim-3201-16","url":null,"abstract":"","PeriodicalId":502111,"journal":{"name":"Le infezioni in medicina","volume":"32 1","pages":"116-118"},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10917562/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140061721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}